Related Experiment Video

Updated: Jun 4, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β

Fahd Al-Mulla1, Milad S Bitar, May Al-Maghrebi

  • 1Department of Pathology, Faculty of Medicine, Health Sciences Center, Kuwait University, Safat, Kuwait, UK. fahd@al-mulla.org

Cancer Research
|February 10, 2011
PubMed

Insights

Raf kinase inhibitory protein (RKIP) maintains active Glycogen synthase kinase-3β (GSK3β), suppressing cancer progression. RKIP depletion activates a pathway that inactivates GSK3β, promoting tumor invasion and metastasis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Raf kinase inhibitory protein (RKIP) inhibits c-RAF kinase and NF-κB signaling, repressing tumor invasion and metastasis.
  • Glycogen synthase kinase-3β (GSK3β) suppresses tumor progression by downregulating oncogenic pathways like Wnt signaling and cyclin D1 activation.

Purpose of the Study:

  • To investigate the interaction between RKIP and GSK3β.
  • To elucidate the role of RKIP in regulating GSK3β activity and its downstream effects on cancer progression.

Main Methods:

  • Biochemical assays to detect RKIP-GSK3β binding.
  • Western blotting to assess protein levels and phosphorylation states.
  • Analysis of signaling pathways including p38 MAPK, Wnt, and epithelial-mesenchymal transition markers.

Main Results:

  • RKIP directly binds to GSK3 proteins, maintaining GSK3β protein levels and its active form.
  • RKIP depletion leads to oxidative stress-induced p38 MAPK activation, phosphorylating and inactivating GSK3β at T390.
  • This inactivation de-represses GSK3β targets, stabilizing cyclin D for cell-cycle progression and increasing β-catenin, SNAIL, and SLUG, promoting epithelial-mesenchymal transition.
  • RKIP levels positively correlate with GSK3β expression in human colorectal cancer.

Conclusions:

  • The RKIP/GSK3 axis is crucial for maintaining GSK3β activity and suppressing oncogenic signaling.
  • Dysregulation of this axis promotes cancer progression, invasion, and metastasis.
  • The RKIP/GSK3 axis represents a potential therapeutic target and prognostic biomarker for cancer.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: